Decision To Screen For Prostate Cancer Should Include Patients, ACS Panel Says
In Brief: Ozer, Comis Join Allegheny Cancer Centers; Two Cooperative Groups Under Same Roof
FDA News: FDA Eases Two-Trial Standard For Proof Of Drug Efficacy
FDA To Regulate Products From Human Cells, Tissue
NCI Extramural Program: Advisors Approve Concepts For Diagnostic Imaging Trials Group
In Congress: specer, Harkin Pan re-Introduction Of Research Trust Fund
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Johnson and Johnson reaches $5.5B settlement deal over talc lawsuits
- The Directors: New directors Herbst and Gius chart a future built on AI, collaboration, and rural access
- FDA grants Replimune’s RP1 an accelerated approval on third submission after 10:3 vote from advisory committee
Amid political outcry, advisors accept weak data and give sponsor a chance to complete phase III trial - Consumers are increasingly accessing U.S. News rankings of cancer hospitals via AI chatbots
2026 report shows no change in the top-five lineup - What happened at FDA? Replimune approval raises questions









